Purchase Order 75N90022P00513

Award Date 8/26/22
Potential Completion Date 9/30/22
Potential Value $89K
Federal Agency
NIH Clinical Center
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Salt Lake City, UT 84107, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Biofire Defense LLC for the delivery of Biofire Defense reagent kits. The period of performance is from May 13, 2024 to September 30, 2024, with a total ceiling value of $248,000.00. Biofire Defense LLC is a for-profit, limited liability company that manufactures goods related to biological agent identification and infectious disease diagnostics. This award is not associated with any...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $21,275.06 firm fixed price purchase order to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The award is for an emergency order of gastrointestinal and respiratory panel tests, with a completion date of April 3, 2024. Biofire Defense has previously received awards from federal agencies such as the Department of Defense,...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $250,000 firm-fixed price purchase order to Biofire Defense LLC of Salt Lake City, Utah. The purchase order is for reagent supplies and tests for infectious disease panels to support existing instrumentation and validated laboratory tests within the Microbiology Service of the agency's Department of Laboratory Medicine. The solicitation sought these diagnostic testing supplies with no set-aside...
This is a $11,580 firm-fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Biofire Diagnostics LLC, a for-profit biotech company specializing in syndromic infectious disease testing. The contract is for the delivery of unspecified Biofire products and services, with an ultimate completion date of August 3, 2018. Biofire Diagnostics is an established federal contractor, holding multiple indefinite delivery contracts and blanket purchase agreements with...
This is a firm fixed price purchase order awarded by the Bureau of Administration, a civilian federal agency, to Biofire Defense LLC for the delivery of medical supplies. The contract has a ceiling value of $24,000.00 and a completion date of February 3, 2024. There is no set-aside designation for this award. Biofire Defense LLC is a for-profit limited liability company that manufactures and provides biological agent identification products and services to support biodefense and infectious...
This is a $11,317.74 firm fixed price purchase order awarded by the Bureau of Administration, a civilian agency, to Biofire Defense LLC, a for-profit limited liability company. The contract is for the delivery of medical supplies with a completion date of September 28, 2024. There is no set-aside designation for this award. Biofire Defense has previously received other federal prime and subcontract awards as well as a $6.2 million cooperative agreement from the Department of Defense to expand...
This is a firm-fixed price purchase order awarded by the Bureau of Administration, a civilian federal agency, to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract is for a lab order for health units with a total ceiling value of $12,691.53 and an ultimate completion date of January 21, 2024. Biofire Defense has previously received other federal prime contracts and subcontracts to provide a range of goods and...
This is a $84,384 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The award is not associated with a set-aside program. The contract provides for the delivery of molecular diagnostic testing products and services related to infectious disease detection. Biofire Diagnostics LLC has received numerous previous federal contract awards as a prime...
This is a $11,926.98 firm fixed price purchase order awarded by the Bureau of Administration, a civilian federal agency, to Biofire Defense LLC for the delivery of medical supplies. The award has no set-aside designation and has a period of performance through February 2025. Biofire Defense LLC is a manufacturer of biological agent identification products, including the Biofire FilmArray and RAZOR Mk II systems, and has previously received prime and subcontract awards from the Department of...
This is a firm fixed price purchase order contract awarded by the Bureau of Administration, a civilian federal agency, to Biofire Defense LLC for the delivery of medical supplies. The contract has a ceiling value of $17,254.06 and a performance period through March 13, 2024. Biofire Defense, a for-profit limited liability company and manufacturer, has previously received other federal contract and grant awards related to biological agent identification, infectious disease testing, and COVID-19...

This is a firm-fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Biofire Defense, LLC for the procurement of reagent supplies for clinical patient care testing. The award was made on a sole-source basis, as Biofire Defense is the sole developer and manufacturer of the specific instruments and reagents required by the NIH. The initial purchase order is for a 3-month period and has a ceiling value of $88,663.50. Biofire Defense has previously received prime and subcontract awards from various federal agencies, including the Department of Defense and Department of Health and Human Services, for the provision of biological threat detection, infectious disease testing, and COVID-19 diagnostic products and services. This award is not associated with a set-aside.

Generated 4/2/25, 4:56 PM